Alnylam Pharmaceuticals | ALNY - Ebitda





Ebitda Changement Date
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amgen USD 5.14B 775M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Incyte USD 367.97M 46.53M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 5.84B 235M 2025-09
PTC Therapeutics USD -70.99M 91.62M 2025-12
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Sanofi EUR 5.66B 3.77B 2025-09
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Takeda JPY 150.25B 297.88B 2026-03
Tectonic Therapeutic USD -21.18M 365K 2025-12
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03
Xencor USD -51.05M 55.28M 2025-12